Antiretroviral therapy coverage for PMTCT in Cameroon
Cameroon: Antiretroviral therapy coverage for PMTCT was 59.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Cameroon, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
Cameroon recorded 59.0% for antiretroviral therapy coverage for pmtct in 2024.
The figure is down 18.1% on the previous year and down 32.2% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Cameroon peaked at 97.0% in 2017 and was at its lowest, 0.0%, in 2000.
That places Cameroon 62nd out of 84 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Cameroon, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 4.0% | — |
| 2003 | 8.0% | +100.0% |
| 2004 | 13.0% | +62.5% |
| 2005 | 11.0% | -15.4% |
| 2006 | 24.0% | +118.2% |
| 2007 | 24.0% | +0.0% |
| 2008 | 33.0% | +37.5% |
| 2009 | 30.0% | -9.1% |
| 2010 | 47.0% | +56.7% |
| 2011 | 55.0% | +17.0% |
| 2012 | 65.0% | +18.2% |
| 2013 | 88.0% | +35.4% |
| 2014 | 87.0% | -1.1% |
| 2015 | 91.0% | +4.6% |
| 2016 | 94.0% | +3.3% |
| 2017 | 97.0% | +3.2% |
| 2018 | 95.0% | -2.1% |
| 2019 | 77.0% | -18.9% |
| 2020 | 77.0% | +0.0% |
| 2021 | 83.0% | +7.8% |
| 2022 | 79.0% | -4.8% |
| 2023 | 72.0% | -8.9% |
| 2024 | 59.0% | -18.1% |
Cameroon compared with similar countries
- Cameroon's 59.0% is below the median for lower middle income countries, which is 83.5%, 71% of the median. (32 countries reporting)
- Cameroon's 59.0% is below the median for Sub-Saharan Africa, which is 82.0%, 72% of the median. (41 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 14.7% | 0.0% | 33.0% | 10 |
| 2010s | 79.6% | 47.0% | 97.0% | 10 |
| 2020s | 74.0% | 59.0% | 83.0% | 5 |
Countries ranked near Cameroon
More health data for Cameroon
- Un projection of annual infant deaths, annual growth rate -1.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7821 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 786.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12,841 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 17 (2025)
- Population ages 00-04, female, annual growth rate 1.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0746 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.21 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Cameroon?
- Antiretroviral therapy coverage for pmtct in Cameroon was 59.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Cameroon?
- The highest recorded value was 97.0% in 2017.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Cameroon?
- The lowest recorded value was 0.0% in 2000.
- How does Cameroon rank for antiretroviral therapy coverage for pmtct?
- Cameroon ranks 62nd out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Cameroon?
- Over the last ten years it is down 32.2%. The long-run trend across the full record is volatile.
- Where does this Cameroon data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).